Advertising for Weight Watchers promoting the availability on GLP-1 drugs seen in the subway in New York on Sunday, January 11, 2026
Whether youre visiting family over the holidays, taking a spring break vacation, or heading out of state for a business trip
New Science Suggests Semaglutide Improves CV Outcomes Beyond Weight Loss Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing serious COVID-19-related events and improving heart failure (HF) symptoms, according to six new substudies published in JACC
Its effects on insulin sensitivity, fat oxidation, and appetite suppression continue even after significant weight loss, allowing individuals to maintain a healthier weight in the long run
Clean Label & Third-Party Tested: Non-GMO, Gluten-Free, and Halal Certified
The appetite suppression provides a window of opportunity to establish sustainable habits